Low levels of vascular endothelial growth factor B predict left ventricular remodeling after acute myocardial infarction

Journal of Cardiac Failure

Volumn 18, Issue 4, 2012, Pages 330-337

  Devaux, Yvan ^a   Vausort, Melanie ^a   Azuaje, Francisco ^a   Vaillant, Michel ^b   Lair, Marie Lise ^c   Gayat, Etienne ^d,h   Lassus, Johan ^e   Ng, Leong L ^f   Kelly, Dominic ^f   Wagner, Daniel R ^a,g   Squire, Iain B ^f  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b Methodology Statistics Competence Center   (Luxembourg)

^c Center for Health Studies   (Luxembourg)

^d Department of Anesthesia and Intensive Care   (France)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF LEICESTER   (United Kingdom)

^g Centre Hospitalier   (Luxembourg)

^h SAINT LOUIS HOSPITAL   (France)

Author keywords

biomarker; Cardiac repair; growth factor; prognostic

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; TROPONIN I; VASCULOTROPIN B;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANGIOGENESIS; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE REMODELING; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROVASCULARIZATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SMOKING HABIT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VENTRICULAR REMODELING;

EID: 84859215801     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.01.010     Document Type: Article

References (33)

1. P.J. de Kam, G.L. Nicolosi, A.A. Voors, M.P. van den Berg, J. Brouwer, and D.J. van Veldhuisen Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 data Eur Heart J 23 2002 536 542
2. B.L. Gerber, C.E. Rochitte, J.A. Melin, E.R. McVeigh, D.A. Bluemke, and K.C. Wu Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction Circulation 101 2000 2734 2741
3. L. Bolognese, N. Carrabba, G. Parodi, G.M. Santoro, P. Buonamici, and G. Cerisano Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction Circulation 109 2004 1121 1126
4. R. Nijveldt, A.M. Beek, A. Hirsch, M.G. Stoel, M.B. Hofman, and V.A. Umans Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury J Am Coll Cardiol 52 2008 181 189
5. B. Olofsson, K. Pajusola, A. Kaipainen, G. von Euler, V. Joukov, and O. Saksela Vascular endothelial growth factor B, a novel growth factor for endothelial cells Proc Natl Acad Sci U S A 93 1996 2576 2581
6. Y. Devaux, F. Azuaje, M. Vausort, C. Yvorra, and D.R. Wagner Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction Funct Integr Genomics 10 2010 329 337
7. F. Azuaje, Y. Devaux, M. Vausort, C. Yvorra, and D.R. Wagner Transcriptional networks characterize ventricular dysfunction after myocardial infarction: a proof-of-concept investigation J Biomed Inform 43 2010 812 819
8. D. Kelly, G. Cockerill, L.L. Ng, M. Thompson, S. Khan, and N.J. Samani Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study Eur Heart J 28 2007 711 718
9. E. Frank, M. Hall, L. Trigg, G. Holmes, and I.H. Witten Data mining in bioinformatics using Weka Bioinformatics 20 2004 2479 2481
10. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
11. M.J. Pencina, R.B. D'Agostino Sr., and E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
12. E.W. Steyerberg, M.J. Pencina, H.F. Lingsma, M.W. Kattan, A.J. Vickers, and B. Van Calster Assessing the incremental value of diagnostic and prognostic markers: a review and illustration Eur J Clin Invest 42 2012 216 228
13. J.L. Mega, D.A. Morrow, J.A. De Lemos, M.S. Sabatine, S.A. Murphy, and N. Rifai B-Type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy J Am Coll Cardiol 44 2004 335 339
14. M.S. Sabatine, D.A. Morrow, J.A. de Lemos, C.M. Gibson, S.A. Murphy, and N. Rifai Multimarker approach to risk stratification in nonST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide Circulation 105 2002 1760 1763
15. J.A. de Lemos, D.A. Morrow, J.H. Bentley, T. Omland, M.S. Sabatine, and C.H. McCabe The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
16. S. Talwar, I.B. Squire, P.F. Downie, A.M. McCullough, M.C. Campton, and J.E. Davies Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction Eur Heart J 21 2000 1514 1521
17. A.M. Richards, M.G. Nicholls, E.A. Espiner, J.G. Lainchbury, R.W. Troughton, and J. Elliott B-Type natriuretic peptides and ejection fraction for prognosis after myocardial infarction Circulation 107 2003 2786 2792
18. D. Kelly, S.Q. Khan, M. Thompson, G. Cockerill, L.L. Ng, and N. Samani Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction Eur Heart J 29 2008 2116 2124
19. R. Serpi, A.M. Tolonen, J. Huusko, J. Rysa, O. Tenhunen, and S. Yla-Herttuala Vascular endothelial growth factor-B gene transfer prevents angiotensin II-induced diastolic dysfunction via proliferation and capillary dilatation in rats Cardiovasc Res 89 2010 204 213
20. C. Fischer, M. Mazzone, B. Jonckx, and P. Carmeliet FLT1 and its ligands VEGFB and PlGF: drug targets for antiangiogenic therapy? Nat Rev Cancer 8 2008 942 956
21. D. Tirziu, E. Chorianopoulos, K.L. Moodie, R.T. Palac, Z.W. Zhuang, and M. Tjwa Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice J Clin Invest 117 2007 3188 3197
22. X. Li, M. Tjwa, I. Van Hove, B. Enholm, E. Neven, and K. Paavonen Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium Arterioscler Thromb Vasc Biol 28 2008 1614 1620
23. T. Karpanen, M. Bry, H.M. Ollila, T. Seppanen-Laakso, E. Liimatta, and H. Leskinen Overexpression of vascular endothelial growth factor-b in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy Circ Res 103 2008 1018 1026
24. M. Bry, R. Kivela, T. Holopainen, A. Anisimov, T. Tammela, and J. Soronen Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation Circulation 122 2010 1725 1733
25. Y. Li, F. Zhang, N. Nagai, Z. Tang, S. Zhang, and P. Scotney VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats J Clin Invest 118 2008 913 923
26. J.S. Silvestre, R. Tamarat, T.G. Ebrahimian, A. Le-Roux, M. Clergue, and F. Emmanuel Vascular endothelial growth factor-B promotes in vivo angiogenesis Circ Res 93 2003 114 123
27. Bry M, Kivela R, Holopainen T, Anisimov A, Tammela T, Soronen J, et al. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation;122:1725-33.
28. K. Aase, G. von Euler, X. Li, A. Ponten, P. Thoren, and R. Cao Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect Circulation 104 2001 358 364
29. D. Bellomo, J.P. Headrick, G.U. Silins, C.A. Paterson, P.S. Thomas, and M. Gartside Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia Circ Res 86 2000 E29 E35
30. J.E. Lahteenvuo, M.T. Lahteenvuo, A. Kivela, C. Rosenlew, A. Falkevall, and J. Klar Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms Circulation 119 2009 845 856
31. F. Zhang, Z. Tang, X. Hou, J. Lennartsson, Y. Li, and A.W. Koch VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis Proc Natl Acad Sci U S A 106 2009 6152 6157
32. C.E. Hagberg, A. Falkevall, X. Wang, E. Larsson, J. Huusko, and I. Nilsson Vascular endothelial growth factor B controls endothelial fatty acid uptake Nature 464 2010 917 921
33. D.R. Wagner, C. Delagardelle, I. Ernens, D. Rouy, M. Vaillant, and J. Beissel Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction J Card Fail 12 2006 66 72